Pharmafile Logo
Pharmafocus logo
Advanced Search

Eisai to enter Russia with epilepsy launch

June 27, 2012
Sales and Marketing Eisai, Russia, Zonegran, emerging markets, epilepsy

Eisai is to enter the Russian market for the first time with the launch of epilepsy drug Zonegran. Entry into the …

News

Roche cuts 1,000 R&D jobs

June 27, 2012
Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts

Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …

News
Roche image

Roche’s Perjeta increases survival

June 27, 2012
Research and Development, Sales and Marketing EMA, FDA, Herceptin, Perjeta, Roche, breast cancer

Roche’s new drug Perjeta has scored another trial success by increasing overall survival in certain breast cancer patients. The new …

News

London Trust on the brink of going bust

June 26, 2012
Sales and Marketing Lansley, NHS, South London Healthcare, reforms

For the first time in its history an NHS Trust is facing bankruptcy and could be dissolved by the government. …

News
Shire image

Generic approval for Shire’s hyperactivity drug

June 26, 2012
Sales and Marketing ADHD, Adderall XR, FDA, IMS Health, Impax, Shire, Teva

US regulators have delivered a blow to Shire by allowing Actavis Group to produce a generic version of its hyperactivity …

News
Roche image

Roche earmarks $300m for diagnostics HQ

June 26, 2012
Manufacturing and Production Diagnostics, Illumina, Roche, US, manufacturing

Roche has said it intends to invest $300 million over the next 10 years at its diagnostics headquarters in Indianapolis, …

News

Pharma manufacturing news in brief

June 26, 2012
Manufacturing and Production Cook Pharmica, Ubichem Fine Chemicals, Unilife Corp, West Pharmaceutical Services

Unilfe wins a new syringe contract, West Pharma signs a deal with Amgen, plus facility updates from Cook Pharmica and …

News
FDA image

FDA looks to start supply chain security programme

June 26, 2012
Manufacturing and Production CDER, FDA, OMB, ORA, manufacturing

The FDA has submitted a formal application to start a supply chain security pilot programme for overseas manufacturers of finished …

News
Eliquis image

FDA delays Eliquis approval

June 26, 2012
Sales and Marketing BMS, Eliquis, FDA, Pfizer, Xarelto

The FDA has asked Pfizer and Bristol-Myers Squibb for more information about its key blood thinner Eliquis. The US regulator …

News
Novartis image

Pharma companies share $400m US biosecurity contract

June 26, 2012
Manufacturing and Production Emergent BioSolutions, GSK, Novartis, manufacturing

GlaxoSmithKline, Novartis and Emergent BioSolutions will share a $400 million contract from the US government to provide vaccine manufacturing capacity …

News
Xarelto image

FDA rejects licence extension for Xarelto

June 26, 2012
Sales and Marketing ACS, Bayer, FDA, J&J, JJ, Pradaxa, Xarelto

The FDA has set a Complete Response Letter to Bayer and J&J over its blood thinner Xarelto. The firms, which …

News

MPs find NHS bodies still blocking treatments

June 25, 2012
Sales and Marketing CCGs, MPs, NHS, NICE, PCTs, Pfizer, viagra

The Labour party has uncovered new restrictions to treatments and drugs in the NHS, which it says is hurting patients …

News

Steve Bates appointed chief executive of the BioIndustry Association

June 25, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Genzyme, Steve Bates

The BioIndustry Association (BIA) has appointed Steve Bates as its chief executive. Bates has worked both in biotech and the …

Appointment
roche_glass_building

Roche failed to investigate 80,000 safety incidents

June 25, 2012
Manufacturing and Production, Sales and Marketing EMA, MHRA, Roche, pharmacovigilance

The European Medicines Agency is investigating Roche after ‘deficiencies’ in the manufacturer’s pharmacovigilance processes came to light. It has emerged …

News
Pfizer image

Pfizer Gaucher drug rejected by CHMP

June 25, 2012
Sales and Marketing Elelyso, FDA, Gaucher, Pfizer, Shire, Vpriv

A European committee has refused marketing authorisation for Pfizer’s Gaucher disease drug Elelyso, as a competitor drug has exclusivity to …

News

The European Medicines Group: focused on UK market access

June 25, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMG, NICE, VBP, market access

Maintaining a dialogue with government, NHS organisations and other stakeholder groups is essential for pharma companies in the UK, and …

Feature
ABPI image

MP criticises drug shortages

June 25, 2012
Sales and Marketing ABPI, Labour, NHS, Whitehead, shortages

A Labour MP has attacked major drug shortages in England that are seeing fewer drugs available to patients in the …

News

Takeda makes changes to organisation

June 22, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda

Takeda has announced the change of senior leadership and the establishment of a new organisation.Effective from July Masahiro Fujimaki becomes …

Appointment

Afinitor recommended in Europe for breast cancer

June 22, 2012
Sales and Marketing Afinitor, CHMP, Cancer, Novartis, breast

A European committee is recommending Novartis’ Afinitor to treat women with a certain type of breast cancer. The CHMP says …

News
Pfizer image

Pfizer vows to learn from virtual trial failure

June 22, 2012
Medical Communications Pfizer, REMOTE, Think science now, digital

Several months after Pfizer failed to recruit patients to its first ever virtual trial, the firm said it was looking …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026